Daily profile of arterial and central aortic pressure in patients with arterial hypertension and non-alcoholic fatty liver disease
https://doi.org/10.21886/2712-8156-2023-4-1-61-67
Abstract
Оbjective: to evaluate the features of daily monitoring of arterial and central aortic pressure in patients with arterial hypertension and non-alcoholic fatty liver disease. Materials and methods: a comparative cross-sectional study was conducted, which involved 120 patients (continuous sample, unorganized population), aged 45 to 65 years (mean age 56.2±8.8 years), including men (34 (28.3%) with AH stage I–II, 1–2 degree. The main group included 60 patients with hypertension and NAFLD, the control group included 60 patients with isolated hypertension. When examining patients, a clinical examination was carried out: taking an anamnesis, measuring "office" blood pressure, anthropometric parameters, calculating body mass index (BMI), WC. 24-hour monitoring of arterial (ABPM) and central aortic pressure (CAP) was assessed using the BPLab complex and Vasotens 24 software (LLC Petr Telegin, Russia). The SCORE scale was used to calculate total cardiovascular risk and 10-year fatal risk. Results: all patients of the study groups underwent ABPM. It was proved that in the patients of the main group, the IV SBP and IV DBP during the day and night significantly exceeded the similar parameters of patients in the comparison group (IV SBP: p=0.0019, p=0.007; IV DBP: p=0.009, p=0.009, respectively). One of the important criteria for assessing blood pressure was the determination of the degree of nighttime decrease in SBP and DBP — the daily index (SI), characterizing the balance in the work of the sympathetic and parasympathetic parts of the autonomic nervous system. In the main group, compared with the control group, there were more patients with SI DBP in the range from 0.0% to 10.0% (non-dipper) (p=0.034), with an increase in SBP at night (night-picker) (p=0.031). When assessing the parameters of CAP, in patients with AH and NAFLD, statistically significantly higher values of mean daily systolic (SADAo) and diastolic (DADo) aortic pressure were observed (p=0.016, p=0.039, respectively), SBP in the daytime (p=0.027), SADao and DADAO at night (p=0.002, p=0.003, respectively), compared with patients with isolated hypertension. Calculation of the risk of cardiovascular complications, in patients with hypertension and NAFLD, a significant increase in the 10-year risk of cardiovascular events was determined, compared with patients with isolated hypertension (3.7 (1.6; 6.0) vs 2.0 (0.6 ;4.3) %, p=0.013). Conclusion: according to the results of 24-hour BP monitoring, in patients with AH and NAFLD, compared with patients with isolated AH, a more significant increase in mean SBP and DBP, an increase in the rate of morning rise and BP variability, and the hypertension time index were revealed. In the main group, patients with a nocturnal increase in SBP were detected significantly more often, which indicates a greater risk of cardiovascular complications in patients with hypertension and NAFLD. In addition, compared with patients with isolated AH, patients with AH and NAFLD showed more significant increases in average daily and nighttime SBPao and DADAO.
About the Authors
M. E. StatsenkoRussian Federation
Mikhail E. Statsenko, Prof., Dr. Sci. (Med.), Vice-Rector for Research, Head of the Department of Internal Medicine
Volgograd
A. M. Streltsova
Russian Federation
Anastasia M. Streltsova, аssistant of the Department of Internal Medicine
Volgograd
References
1. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.)] doi: 10.15829/1560-4071-2020-3-3786.
2. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. ESC Scientific Document Group, 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the manage-ment of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104, doi:10.1093/eurheartj/ehy339.
3. Ivashkin V.T., Maevskaya M.V., Zharkova M.S., Kotovskaya Yu.V., Tkacheva O.N. et al. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-140.] doi.org/10.22416/1382-4376-2022-32-4-104-140.
4. Yan-Ci Zhao, Guo-Jun Zhao, Ze Chen, Zhi-Gang She, Jingjing Cai, Hongliang Li. Nonalcoholic Fatty Liver Disease An Emerging Driver of Hypertension. Hypertension. 2020. Volume 75, Issue 2: 275–284. doi:10.1161/HYPERTENSIONAHA.119.13419
5. Drapkina O.M., Korneeva O.N. Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk. Rational Pharmacotherapy in Cardiology. 2016;12(4):424-429. doi: 10.20996/1819-6446-2016-12-4-424-429
6. Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Sci Rep. 2016 Sep 16;6:33386. doi: 10.1038/srep33386.
7. ABC-H Investigators, Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P et al. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens. 2014;32(12):2332–2340; discussion 2340.
8. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35(26):1719–1725.
9. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint Recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)/ Ramon C. Hermida, Mikhail H. Smolensky, Diana E. Ayala [et al.] // Chronobiol. Int.– 2013. – Vol. 30, № 3. – P. 355-410.
10. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370 (9594):1219–1229.
11. Cicek Y, Durakoglugil ME, Kocaman SA, Cetin M, Erdogan T, Dogan S et al. Non-dipping pattern in untreated hypertensive patients is related to increased pulse wave velocity independent of raised nocturnal blood pressure. Blood Press. 2013;22(1):34–38.
12. Cuspidi C, Sala C, Tadic M, Gherbesi E, Grassi G, Mancia G. Nondipping pattern and carotid atherosclerosis: a systematic review and meta-analysis. J Hypertens. 2016;34(3):382– 385.
13. Fan H‑Q, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28(10):2036–2045.
Supplementary files
Review
For citations:
Statsenko M.E., Streltsova A.M. Daily profile of arterial and central aortic pressure in patients with arterial hypertension and non-alcoholic fatty liver disease. South Russian Journal of Therapeutic Practice. 2023;4(1):61-67. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-1-61-67